Methylene blue for vasoplegic syndrome treatment in heart surgery. Fifteen years of questions, answers, doubts and certainties

Objective: There is strong evidence that methylene blue (MB), an inhibitor of guanylate cyclase, is an excellent therapeutic option for vasoplegic syndrome (VS) treatment in heart surgery. The aim of this article is to review the MB’s therapeutic function in the vasoplegic syndrome treatment. Metho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery
Main Authors: Paulo Roberto Barbosa EVORA, Paulo José de Freitas RIBEIRO, Walter Vilella de Andrade VICENTE, Celso Luís dos REIS, Alfredo José RODRIGUES, Antonio Carlos MENARDI, Lafaiete ALVES JUNIOR, Patrícia Martinez EVORA, Solange BASSETTO
Formato: Artigo
Idioma:Inglês
Publicado em: Sociedade Brasileira de Cirurgia Cardiovascular 2009
Assuntos:
Medicina
drug effects
Methylene blue
Vascular diseases
Vascular resistance
Extracorporeal circulation
Acesso em linha:https://www.redalyc.org/articulo.oa?id=398941872005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados